Developing a Virtual Reality (VR)-Based Prototype for Perioperative Care - a Proof of Concept Study

Sponsor
Changi General Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05564013
Collaborator
KK Women's and Children's Hospital (KKH) (Other)
160
1
2
11
14.5

Study Details

Study Description

Brief Summary

Preoperative anxiety and acute post-operative pain are common and have been associated with the development of chronic post-surgical pain and longer hospitalisation. Pharmacological interventions to combat anxiety and pain come with their attendant adverse effects. Therefore, non-pharmacological strategies- Virtual Reality (VR) has gained popularity to improve overall the perioperative experience for patients.

Our overall aim is to develop and evaluate the use of a VR-based prototype to reduce pre-operative anxiety and post-operative acute pain intensity in our local patient population. Our primary aim is to reduce preoperative anxiety as measured by a reduction in Visual Analogue Score-Anxiety (VAS-A) by a mean of 2.5 points pre-post VR intervention. Our secondary aims are to reduce post-operative acute pain and to achieve more than 50% good to excellent self-reported satisfaction on our VR prototype.

Condition or Disease Intervention/Treatment Phase
  • Device: Virtual reality
N/A

Detailed Description

This will be a multi-center, prospective cohort study to be conducted in Changi General Hospital (CGH) and KKH, in collaboration with industry partner, Vue Networks. The patients will provide written informed consent for the study.

Phase 1: To facilitate the development of VR application that is suitable for perioperative care management, a survey will be conducted in 100 subjects (CGH: n=50; KKH: n=50) to gather patient preference and feedback with needs analysis.

The VR application development needs analysis would focus on:
  1. instructional module on surgical journey; and ii) mindfulness module with inputs from perspectives of clinical health psychology iii) local relaxation scenarios (e.g. village, botanic gardens, Changi beach, Gardens by the bay); iv) feedback on hardware, i.e., VR headset usability.
Phase 2: The testing of the developed VR application will be performed in 60 subjects (CGH:

n=30; KKH: n=30).

The study will utilize Head-Mounted Displays (HMD) such as the PicoG2 4K, the Oculus Go and/or Quest headsets. In immersive VR, high resolution 360-degree video and/or 3D computer graphics are paired with suitable ambience sounds and audio cues to fully immerse the user in the selected environment. The contents comprise a mixture of live-action and/or animation, as well as local settings. The domain components of the VR intervention include:

  • VR application for pre-operative anxiety and post-operative acute pain treatment with local context;

  • Patient feedback on local scenarios and content of VR and mindfulness;

  • Development of VR application: Vue Networks' platform with local and foreign context scenarios, passive and active scenario features, development of mindfulness application, language use for mindfulness application.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
160 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Intervention Model Description:
Multi-center, prospective cohort studyMulti-center, prospective cohort study
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Developing a Virtual Reality (VR)-Based Prototype for Perioperative Care - a Proof of Concept Study
Anticipated Study Start Date :
Oct 1, 2022
Anticipated Primary Completion Date :
Sep 1, 2023
Anticipated Study Completion Date :
Sep 1, 2023

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Phase 1 - Patient feedback and needs analysis

To facilitate the development of virtual reality application that is suitable for perioperative care management, a survey will be conducted in 100 subjects to gather patient preference and feedback with needs analysis.

Experimental: Phase 2 - Evaluation of prototype efficacy

Comparison of pre-operative anxiety and post-operative pain in 60 patients before and after intervention using the developed virtual reality application.

Device: Virtual reality
Up to 25 minutes of virtual reality exposure in supine position

Outcome Measures

Primary Outcome Measures

  1. Pre-operative anxiety [up to 1hour]

    Anxiety score - VAS-A (0 to 10; 0-best outcome, 10-worst outcome)

Secondary Outcome Measures

  1. Post-operative pain [up to 1hour]

    Pain score - Numerical Rating Scale (0 to 10; 0-best outcome, 10-worst outcome)

  2. User satisfaction [up to 1hour]

    Self-reported satisfaction score (0 to 10; 0-worst outcome, 10-best outcome)

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adult patients aged 21 years old and above and undergoing scheduled surgery;

  • American Society of Anesthesiologist physical status I to III, with no visual or hearing impairment; and

  • Understands English or Chinese.

Exclusion Criteria:
  • Comorbidities affecting usage of virtual reality e.g., giddiness, motion sickness, claustrophobia, stroke, seizure, dementia, transmissible diseases, severe facial eczema; and

  • Unable to understand the administered questionnaires.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Changi General Hospital Singapore Singapore 529889

Sponsors and Collaborators

  • Changi General Hospital
  • KK Women's and Children's Hospital (KKH)

Investigators

  • Principal Investigator: Lydia Weiling Li, Changi General Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Lydia Li Weiling, Consultant, Department of Anaesthesia and Surgical Intensive Care, Changi General Hospital
ClinicalTrials.gov Identifier:
NCT05564013
Other Study ID Numbers:
  • VIRTUAL02
First Posted:
Oct 3, 2022
Last Update Posted:
Oct 3, 2022
Last Verified:
Sep 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Lydia Li Weiling, Consultant, Department of Anaesthesia and Surgical Intensive Care, Changi General Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 3, 2022